Thank you, Mr. Chair.
I'd like to welcome all our witnesses.
I'm going to start with Dr. Elaine Hyshka. In your opening remarks, you talked about the shift in drug supply. I just wanted to get clarification from you, and probably a bit of expansion.
Is the shift in the drug supply an independent phenomenon? Is it a phenomenon as a result of, let's say, access to safe supply and how it might not be as readily available? Is the shift unique only to Alberta, or have you seen it across Canada?